Results 231 to 240 of about 1,232,473 (312)

The Serotonin 2B (5‐HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Major depressive disorder (MDD) and treatment‐resistant depression (TRD) remain leading causes of disability, providing the impetus for receptor‐level treatment strategies beyond monoamine reuptake. The serotonin 5‐HT2B receptor (5‐HT2BR) is uniquely positioned at the interface of central‐antidepressant mechanisms and peripheral cardiac risks.
Gia Han Le   +8 more
wiley   +1 more source

Nutrient patterns and risk of diabetes mellitus type 2: a case-control study. [PDF]

open access: yesBMC Endocr Disord
Haramshahi M   +10 more
europepmc   +1 more source

Challenges and Pitfalls to Diagnosing NUTM1‐Rearranged Neoplasia of the Pancreas by Cytology and Ancillary Studies

open access: yesDiagnostic Cytopathology, EarlyView.
ABSTRACT Fine‐needle aspiration cytology specimens are frequently utilized for ancillary studies to identify diagnostic and prognostic information. This case highlights diagnostic pitfalls and challenges in diagnosing NUTM1‐rearranged neoplasia on pancreatic cytology.
Terrance J. Lynn
wiley   +1 more source

Type 2 Diabetes Mellitus and Macrovascular Complications

open access: yesInternational Journal of Endocrinology, 2017
Peng-Fei Shan   +3 more
doaj   +1 more source

Investigation of Metformin Contamination in Horses: Implications for Environmental Exposure and Doping Control

open access: yesDrug Testing and Analysis, EarlyView.
The widespread use of metformin in human medicine coupled with the detection of metformin in blood and urine samples collected from racehorses has raised concern about the potential for exposure from contaminated stalls. This study describes blood and urine concentrations in horses following intentional exposure of horses to metformin contaminated ...
Megan E. Jacobs   +5 more
wiley   +1 more source

Cannabidiol in Anorexia Nervosa: A Double‐Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Anorexia nervosa (AN) is a severe psychiatric disorder marked by an intense fear of gaining weight and persistent body dissatisfaction, both during periods of underweight and after weight restoration. The endocannabinoid system may offer therapeutic benefits, particularly in reducing anxiety.
Neha Sahota   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy